Fee Schedule Instructions

Total Page:16

File Type:pdf, Size:1020Kb

Fee Schedule Instructions Last Updated on: 9/3/2021 Fee Schedule Instructions Historical Behavioral Health Fee Schedules Fee Schedule Formats Format of CSV Fee Schedules Special Indicators on Fee Schedules Table Listing Fee Schedule Instructions Welcome to the Connecticut Medical Assistance Program enhanced fee schedule page. The fee schedules have been enhanced to provide different formats that can be easily viewed, downloaded and manipulated, and that have historical rate data. To reference provider bulletins with important fee schedule information, navigate to the Information page of this Web site by selecting Information > Publications and use the Publication Search feature to find provider bulletins for your provider type. Limited policy restriction information is only provided on the fee schedule. For a comprehensive set of policy information, please refer to Chapter 7 of the Provider Manual. To reference provider manuals, navigate to the Information page of this Web site by clicking on Information > Publications > Provider Manuals to find the provider manual for your provider type and click the “View Chapter 7” button. For enhanced pediatric and obstetrical services rate information, please review further down in the document the section titled Available Fee Schedules and the information provided under the “additional information column” for both the “Physician Office and Outpt Services” fee schedule. Historical Behavioral Health Fee Schedules This link contains Behavioral Health Partnership & Psychologist fee schedules produced prior to April 1, 2012. Fee Schedule Formats The most current fee schedules are now available in one of two formats as follows: o PDF –Portable Document Format - Fee schedules in this format (easily viewed and printed with free Adobe Acrobat Reader) contain footnoted information pertaining to some specific policies related to the procedure codes. This is a picture that cannot be sorted or modified in any way. This document can be saved to your PC. It is 1 important to note that this version is updated annually or when there are significant numbers of updates. o CSV – Comma Separated Values - A CSV file type can be opened in Microsoft Excel or other spreadsheet programs. This file type is available to providers in the event that providers would like to use the fee schedule data for any necessary calculations. This fee schedule format can be manipulated as any other Excel document, with available spreadsheet features such as sorting, filtering, and adding columns. Please note the following tips when using the CSV format. o To open a fee schedule in this format, simply click on the CSV link next to the appropriate fee schedule. On the Pop Up box that appears, press the Save button and Save in the folder of your choice and with the name of your choice. Go to folder where the file was saved and open the file. After it is open, save the file in the desired spreadsheet program by selecting the file type, such as Microsoft Excel. o Once the file is opened, providers will have to expand the column size of each of the columns. Providers may then perform any functions available in the selected spreadsheet program, such as sort, filter, print, and add columns. o If the provider is interested only in current rates and not historical rate data, use the filter function of the selected spreadsheet program to filter by the effective date. If the provider is interested in viewing current and historical rate information, do not apply a filter. o If the fee schedule is to be printed, it may be wise to choose landscape and add page numbers using the page number feature of the selected spreadsheet program. o If the CSV link doesn’t work for you, you may need to point to the link, right click and select Open to access the CSV format and/or on the pop-up blocker setting page there is a drop down with the Blocking level. If you have this set to "High" Then you need to override the popup blocker settings. You can investigate your settings in either of these ways: ▪ Tools | Pop-up blocker | Pop-up Blocker Settings | set the Blocking level to Medium ▪ Tools | Internet Options | Privacy tab | Click the Settings button in the pop- up blocker area | set the Blocking level to Medium Format of CSV Fee Schedules Each fee schedule contains the following data: • Heading – Indicates the name of the fee schedule. • Procedure Code – Indicates each procedure code that can be billed for that fee schedule. • Proc description – Includes a description of each procedure code. 2 • Mod1 – Includes any modifiers that can be billed with the procedure code. Modifiers will not be applicable to all fee schedules. • Mod1 Desc – Includes a description for the listed modifier. Beginning mid-May 2009, this field will be excluded on MEDS Fee Schedules. • Rate Type – The rate type is used to further define the type of rate for the provider fee schedule. Some fee schedules may only have one rate type, whereas others may have multiple rate types. The rate type gives DSS the ability to reimburse procedure codes at a different rate amount based on criteria such as client age or gender. • Max Fee – Indicates the maximum fee payable for that procedure code. • Effective Date – Indicates the effective date for that rate type and max fee amount. The fee schedule may contain multiple rate types, max fee amounts, and effective dates so that providers have historical rate data. • End Date – Indicates the end date for that rate type and max fee amount. • PA – Indicates whether or not prior authorization (PA) is required. If the column contains a value of Y then PA is ALWAYS required for a procedure code. If the PA indicator lists an “*” asterisk; that implies the PA applies to specific billing rule situations, not all. Ensure that you refer to Chapter 7 of the Provider Manual for situational PA requirements as this field shows codes that ALWAYS require PA. To reference provider manuals, navigate to the Information page of this Web site by clicking on Information > Publications > Provider Manuals to find the provider manual for your provider type and click the “View Chapter 7” button. • QTY – Applies only to MEDS fee schedules and indicates the quantity associated with the procedure code Special Indicators on Fee Schedules The Max Fee column lists the amount the procedure code will be reimbursed. Some fee schedules may contain special indicators in the Max Fee column. These indicators are: • MP – Indicates that a procedure code is manually priced. No rate will be listed. • PSR – Indicates that the rate for this procedure code is provider specific. No rate will be listed. • BLLACQ - Indicates to Bill Acquisition Cost. This applies to the Optician Fee Schedule (formerly vision) • %BILL – indicate that code pays a percentage of the claim billed amount. This applies to the Physician Surgical fee schedule. Please note you must do a find on the CSV format of “BILL” to locate the code. This value does not appear in the autofilter list if the CSV is filtered. MEDS Specific Values • Lst-15 – Indicates to be priced at the lesser of list minus 15% based on an appropriate published manufacturer's suggested retail price or Medicare Price if 3 available. Appropriate documentation regarding pricing must be available upon request. • Zero - Indicates that a procedure code is manually priced or requires PA. No rate will be listed. • CST+75 – Indicates for a hearing aid repair, the payment for repairs performed by the manufacturer or third party vendor are limited to the manufacturer or third party vendor's actual costs plus $75. Appropriate documentation regarding pricing must be available upon request. Table Listing The following tables provide fee schedules, rate types and other additional information: Table 1: The Enhanced Fee Schedule table, is a comprehensive listing of all fee schedules. The Rate Type column provides a 2 or 3 digit character value associated with the specific fee schedule that is used to generate the fee schedule. In a limited number of fee schedules, such as the physician fee schedule, the additional notes column contains specific instructions on how to use the Rate Type column. The Available Format column indicates whether the fee schedule is available in PDF or CSV. Table 2: The Rate Type table further defines the rate types used in each fee schedule. Table 3: Lists the Diagnosis Codes for Family Planning Services Table 3a: contains ICD-9-CM codes Table 3b: contains ICD-10-CM codes effective 10/1/2015. Table 4: The HUSKY Health Primary Care Rates lists the services eligible for enhanced payments under the HUSKY Health Primary Care for services furnished by certain primary care physicians. The rates will be effective 01/01/2015 to 12/31/2299. Please refer to bulletin PB-2014-75, PB-2015-44, PB 2017-44 and PB 2017-72 for further information. Table 5: Lists the services eligible for enhanced payments under ACA Section 1202 Increased Payments for Services Furnished by Certain Primary Care Physicians Table 6: Lists Physician Office and Outpatient fee schedule procedure codes payable for 08/527 FQHC billing non-FQHC services physician services - non-mental health. Table 7: Lists Physician Surgery fee schedule procedure codes payable for 08/527 FQHC billing non-FQHC services physician services - non-mental health. Table 8: Lists Physician Office and Outpatient fee schedule procedure codes payable for 08/527 FQHC billing non-FQHC services for mental health services. Table 9: Lists the Physician Office and Outpatient codes for OBS (Obstetrical) rate type ICD-10-CM codes effective 10/1/2015. 4 Table 10: Lists the ICD-10-CM Behavioral Health Diagnosis Codes effective 10/1/2015. Table 11: Lists the ICD-10-CM Pregnancy Diagnosis Codes not requiring PA for Lab Procedures 81220-81224 effective 10/1/2015.
Recommended publications
  • PT - 2020 Measure Value Set Avoidableed
    PT - 2020 Measure Value Set_AvoidableED Numerator Value Set Name Code Definition Code System N/A A09 Infectious gastroenteritis and colitis, unspecified ICD10CM N/A A630 Anogenital (venereal) warts ICD10CM N/A B069 Rubella without complication ICD10CM N/A B070 Plantar wart ICD10CM N/A B078 Other viral warts ICD10CM N/A B079 Viral wart, unspecified ICD10CM N/A B179 Acute viral hepatitis, unspecified ICD10CM N/A B199 Unspecified viral hepatitis without hepatic coma ICD10CM N/A B309 Viral conjunctivitis, unspecified ICD10CM N/A B354 Tinea corporis ICD10CM N/A B355 Tinea imbricata ICD10CM N/A B356 Tinea cruris ICD10CM N/A B483 Geotrichosis ICD10CM N/A B49 Unspecified mycosis ICD10CM N/A B80 Enterobiasis ICD10CM N/A B852 Pediculosis, unspecified ICD10CM N/A B853 Phthiriasis ICD10CM N/A B889 Infestation, unspecified ICD10CM N/A C61 Malignant neoplasm of prostate ICD10CM N/A E039 Hypothyroidism, unspecified ICD10CM N/A E215 Disorder of parathyroid gland, unspecified ICD10CM N/A E780 Pure hypercholesterolemia ICD10CM N/A E786 Lipoprotein deficiency ICD10CM N/A E849 Cystic fibrosis, unspecified ICD10CM N/A G5600 Carpal tunnel syndrome, unspecified upper limb ICD10CM N/A G5601 Carpal tunnel syndrome, right upper limb ICD10CM N/A G5602 Carpal tunnel syndrome, left upper limb ICD10CM N/A H00011 Hordeolum externum right upper eyelid ICD10CM N/A H00012 Hordeolum externum right lower eyelid ICD10CM N/A H00013 Hordeolum externum right eye, unspecified eyelid ICD10CM N/A H00014 Hordeolum externum left upper eyelid ICD10CM N/A H00015 Hordeolum externum
    [Show full text]
  • Rwanda ICD-10 Diagnostic Code Subset
    Rwanda ICD-10 Diagnostic Code Subset ICD 10 code Diagnosis/Description A Infectious and parasitic diseases A00.0 CHOLERA DUE TO VIBRIO CHOLERAE 01_ BIOVAR CHOLERAE A01 TYPHOID AND PARATYPHOID FEVERS A01.0 TYPHOID FEVER A01.4 PARATYPHOID FEVER_ UNSPECIFIED A02 OTHER SALMONELLA INFECTIONS A02.0 SALMONELLA GASTROENTERITIS A02.1 SALMONELLA SEPTICEMIA A02.2 LOCALIZED SALMONELLA INFECTIONS A02.9 SALMONELLA INFECTION_ UNSPECIFIED A03 SHIGELLOSIS A03.0 SHIGELLOSIS DUE TO SHIGELLA DYSENTERIAE A03.2 SHIGELLOSIS DUE TO SHIGELLA BOYDII A03.9 SHIGELLOSIS_ UNSPECIFIED A04 OTHER BACTERIAL INTESTINAL INFECTIONS A04.0 ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION A04.1 ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION A04.4 OTHER INTESTINAL ESCHERICHIA COLI INFECTIONS A04.5 CAMPYLOBACTER ENTERITIS A04.7 ENTEROCOLITIS DUE TO CLOSTRIDIUM DIFFICILE A04.8 OTHER SPECIFIED BACTERIAL INTESTINAL INFECTIONS A04.9 BACTERIAL INTESTINAL INFECTION_ UNSPECIFIED A05 OTHER BACTERIAL FOOD-BORNE INTOXICATIONS A05.0 FOOD-BORNE STAPHYLOCOCCAL INTOXICATION A05.1 BOTULISM A05.4 FOOD-BORNE BACILLUS CEREUS INTOXICATION A05.8 OTHER SPECIFIED BACTERIAL FOOD-BORNE INTOXICATIONS A05.9 BACTERIAL FOOD-BORNE INTOXICATION_ UNSPECIFIED A06 AMEBIASIS A06.0 ACUTE AMEBIC DYSENTERY A06.1 CHRONIC INTESTINAL AMEBIASIS A06.2 AMEBIC NONDYSENTERIC COLITIS A06.3 AMEBOMA OF INTESTINE A06.4 AMEBIC LIVER ABSCESS A06.5 AMEBIC LUNG ABSCESS A06.6 AMEBIC BRAIN ABSCESS A06.7 CUTANEOUS AMEBIASIS A06.8 AMEBIC INFECTION OF OTHER SITES A06.9 AMEBIASIS_ UNSPECIFIED A07.0 BALANTIDIASIS A07.1 GIARDIASIS [LAMBLIASIS]
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0038462 A1 ZHANG Et Al
    US 20160038462A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0038462 A1 ZHANG et al. (43) Pub. Date: Feb. 11, 2016 (54) USE OF NK-1 RECEPTOR ANTAGONISTS IN (60) Provisional application No. 61/838,784, filed on Jun. PRURTUS 24, 2013. (71) Applicant: TIGERCAT PHARMA, INC., South Publication Classification San Francisco, CA (US) (51) Int. Cl. (72) Inventors: Xiaoming ZHANG, Sunnyvale, CA A613 L/403 (2006.01) (US); Edward F. SCHNIPPER, A6II 45/06 (2006.01) Redwood City, CA (US); Andrew J. A619/00 (2006.01) PERLMAN, Stanford, CA (US); James (52) U.S. Cl. W. LARRICK, Sunnyvale, CA (US) CPC ............. A6 IK3I/403 (2013.01); A61 K9/0053 (2013.01); A61 K9/0014 (2013.01); A61 K (21) Appl. No.: 14/922,684 45/06 (2013.01) (57) ABSTRACT (22)22) Filed: Oct. 26,9 2015 The invention relates to methods for treatingg pruritusp with NK-1 receptor antagonists such as serlopitant. The invention O O further relates to pharmaceutical compositions comprising Related U.S. Application Data NK-1 receptorantagonists such as serlopitant. In addition, the (60) Division of application No. 14/312.942, filed on Jun. invention encompasses treatment of a pruritus-associated 24, 2014, now Pat. No. 9,198.898, which is a continu condition with serlopitant and an additional antipruritic ation-in-part of application No. 13/925,509, filed on agent, and the use of serlopitant as a sleep aid, optionally in Jun. 24, 2013, now Pat. No. 8,906,951. combination with an additional sleep-aiding agent. Patent Application Publication Feb.
    [Show full text]
  • 190.18 - Serum Iron Studies
    Medicare National Coverage Determinations (NCD) Coding Policy Manual and Change Report (ICD-10-CM) 190.18 - Serum Iron Studies HCPCS Codes (Alphanumeric, CPT AMA) Code Description 82728 Ferritin 83540 Iron 83550 Iron Binding capacity 84466 Transferrin ICD-10-CM Codes Covered by Medicare Program The ICD-10-CM codes in the table below can be viewed on CMS’ website as part of Downloads: Lab Code List, at http://www.cms.gov/Medicare/Coverage/CoverageGenInfo/LabNCDsICD10.html Code Description A01.00 Typhoid fever, unspecified A01.01 Typhoid meningitis A01.02 Typhoid fever with heart involvement A01.03 Typhoid pneumonia A01.04 Typhoid arthritis A01.05 Typhoid osteomyelitis A01.09 Typhoid fever with other complications A01.1 Paratyphoid fever A A01.2 Paratyphoid fever B A01.3 Paratyphoid fever C A01.4 Paratyphoid fever, unspecified A02.0 Salmonella enteritis A02.1 Salmonella sepsis A02.20 Localized salmonella infection, unspecified NCD 190.18 January 2021 Changes ICD-10-CM Version – Red Fu Associates, Ltd. January 2021 1 Medicare National Coverage Determinations (NCD) Coding Policy Manual and Change Report (ICD-10-CM) Code Description A02.21 Salmonella meningitis A02.22 Salmonella pneumonia A02.23 Salmonella arthritis A02.24 Salmonella osteomyelitis A02.25 Salmonella pyelonephritis A02.29 Salmonella with other localized infection A02.8 Other specified salmonella infections A02.9 Salmonella infection, unspecified A04.0 Enteropathogenic Escherichia coli infection A04.1 Enterotoxigenic Escherichia coli infection A04.2 Enteroinvasive Escherichia
    [Show full text]
  • The Clinical Conundrum of Pruritus Victoria Garcia-Albea, Karen Limaye
    FEATURE ARTICLE The Clinical Conundrum of Pruritus Victoria Garcia-Albea, Karen Limaye ABSTRACT: Pruritus is a common complaint for derma- Pruritus is also the most common symptom in derma- tology patients. Diagnosing the cause of pruritus can tological disease and can be a symptom of several sys- be difficult and is often frustrating for patients and pro- temic diseases (Bernhard, 1994). The overall incidence viders. Even after the diagnosis is made, it can be a chal- of pruritus is unknown because there are no epidemio- lenge to manage and relieve pruritus. This article reviews logical databases for pruritus (Norman, 2003). According common and uncommon causes of pruritus and makes to a 2003 study, pruritus and xerosis are the most com- recommendations for proper and thorough evaluation mon dermatological problems encountered in nursing and management. home patients (Norman, 2003). Key words: Itch, Pruritus INTRODUCTION ETIOLOGY Pruritus (itch) is the most frequent symptom in derma- The skin is equipped with a network of afferent sensory tology (Serling, Leslie, & Maurer, 2011). Itch is the pre- and efferent autonomic nerve branches that respond to dominant symptom associated with acute and chronic various chemical mediators found in the skin (Bernhard, cutaneous disease and is a major symptom in systemic dis- 1994). It is believed that maximal itch production is ease (Elmariah & Lerner, 2011; Steinhoff, Cevikbas, Ikoma, achieved at the basal layer of the epidermis, below which & Berger, 2011). It can be a frustration for both the patient pain is perceived (Bernhard, 1994). Autonomic nerves in- and the clinician. This article will attempt to provide an nervate hair follicles, pili erector muscles, blood vessels, overview of pruritus, a method for thorough and com- eccrine, apocrine, and sebaceous glands (Bernhard, 1994).
    [Show full text]
  • Blood Glucose Testing 2020.Pdf
    National Coverage Determination Procedure Code: 82947, 82948, 82962 Blood Glucose Testing CMS Policy Number: 190.20 See also: Medicare Preventive Services Back to NCD List Description: This policy is intended to apply to blood samples used to determine glucose levels. Blood glucose determination may be done using whole blood, serum or plasma. It may be sampled by capillary puncture, as in the fingerstick method, or by vein puncture or arterial sampling. The method for assay may be by color comparison of an indicator stick, by meter assay of whole blood or a filtrate of whole blood, using a device approved for home monitoring, or by using a laboratory assay system using serum or plasma. The convenience of the meter or stick color method allows a patient to have access to blood glucose values in less than a minute or so and has become a standard of care for control of blood glucose, even in the inpatient setting. Indications: Blood glucose values are often necessary for the management of patients with diabetes mellitus, where hyperglycemia and hypoglycemia are often present. They are also critical in the determination of control of blood glucose levels in patient with impaired fasting glucose (FPG 110-125 mg/dL), patient with insulin resistance syndrome and/or carbohydrate intolerance (excessive rise in glucose following ingestion of glucose/glucose sources of food), in patient with a hypoglycemia disorder such as nesidioblastosis or insulinoma, and in patients with a catabolic or malnutrition state. In addition to conditions listed, glucose testing may be medically necessary in patients with tuberculosis, unexplained chronic or recurrent infections, alcoholism, coronary artery disease (especially in women), or unexplained skin conditions (i.e.: pruritis, skin infections, ulceration and gangrene without cause).
    [Show full text]
  • Read Code Description 14L.. H/O: Drug Allergy 158.. H/O: Abnormal Uterine Bleeding 16C2
    Read Code Description 14L.. H/O: drug allergy 158.. H/O: abnormal uterine bleeding 16C2. Backache 191.. Tooth symptoms 191Z. Tooth symptom NOS 1927. Dry mouth 198.. Nausea 199.. Vomiting 19C.. Constipation 1A23. Incontinence of urine 1A32. Cannot pass urine - retention 1B1G. Headache 1B62. Syncope/vasovagal faint 1B75. Loss of vision 1BA2. Generalised headache 1BA3. Unilateral headache 1BA4. Bilateral headache 1BA5. Frontal headache 1BA6. Occipital headache 1BA7. Parietal headache 1BA8. Temporal headache 1C13. Deafness 1C131 Unilateral deafness 1C132 Partial deafness 1C133 Bilateral deafness 1C14. "Blocked ear" 1C15. Popping sensation in ear 1C1Z. Hearing symptom NOS 22J.. O/E - dead 22J4. O/E - dead - sudden death 22L4. O/E - Wound infected 2542. O/E - dental caries 2554. O/E - gums - blue line 2555. O/E - hypertrophy of gums 2FF.. O/E - skin ulcer 2I14. O/E - a rash 39C0. Pressure sore 39C1. Superficial pressure sore 39C2. Deep pressure sore 62... Patient pregnant 6332. Single stillbirth 66G4. Allergy drug side effect 72001 Enucleation of eyeball 7443. Exteriorisation of trachea 744D. Tracheo-oesophageal puncture 7511. Surgical removal of tooth 75141 Root canal therapy to tooth 7610. Total excision of stomach 7645. Creation of ileostomy 773C. Other operations on bowel 773Cz Other operation on bowel NOS 7826. Incision of bile duct 7840. Total excision of spleen 7B01. Total nephrectomy 7C032 Unilateral total orchidectomy - unspecified 7E117 Left salpingoophorectomy 7E118 Right salpingectomy 7E119 Left salpingectomy 7G321 Avulsion of nail 7H220 Exploratory laparotomy 7J174 Manipulation of mandible 8HG.. Died in hospital 94B.. Cause of death A.... Infectious and parasitic diseases A0... Intestinal infectious diseases A00.. Cholera A000.
    [Show full text]
  • 2019 Texas FI PA Results Ready for Formatting 3-29-20
    2019 Texas Fully Insured Pharmacy Prior Authorization Requests Summary Prior Prior Total % Prior % Prior Appeal Appeal Total % Appeals % Appeals IRO Denials IRO Denials Total % IRO % IRO Authorization Authorization Prior Authorizations Authorizations Denials Denials Appeals Upheld Overturned Upheld Overturned IRO Upheld Overturned Approvals Denials Authorizations Approved Denied Upheld Overturned 23,211 7,514 30,725 76% 24% 235 293 528 45% 55% 7 1 8 88% 13% #Proprietary 1 of 83 2019 Texas Pharmacy Prior Authorization Report by Drug Name and 6-digit GPI Drug Name 1st 6 Prior Prior Total Prior % Prior % Prior Appeal Appeal Total Appeals % Appeals % Appeals IRO Denials IRO Denials Total IRO % IRO % IRO digits of Authorization Authorization Authorizations Authorizations Authorizations Denials Denials Upheld Overturned Upheld Overturned Upheld Overturned GPI Approval Denial Approved Denied Upheld Overturned 1STMEDX-PATC 908599 2 2 0% 100% ABILIFY 592500 6 4 10 60% 40% ABIRATERONE 214060 6 6 100% 0% ABSORICA 900500 47 26 73 64% 36% 1 1 2 50% 50% ACANYA 900599 1 1 2 50% 50% ACCU-CHEK 941000 3 2 5 60% 40% ACETAMINOPHEN CAFFEINE 659913 3 2 5 60% 40% ACETAMINOPHEN CODEINE 659910 192 16 208 92% 8% ACETAZOLAMIDE 371000 9 5 14 64% 36% 2 2 0% 100% ACETAZOLAMIDE 611000 2 2 100% 0% ACIPHEX 492700 6 4 10 60% 40% ACITRETIN 902505 1 1 100% 0% ACTEMRA 665000 17 9 26 65% 35% 2 2 0% 100% ACTICLATE 665000 1 1 100% 0% ACTONEL 300420 1 1 100% 0% ACTOPLUS 279980 1 1 100% 0% ACZONE 900510 248 11 259 96% 4% ADAPALENE 900500 11 2 13 85% 15% ADAPALENE 900599 13 5
    [Show full text]
  • Icd-10Causeofdeath.Pdf
    A00 Cholera A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae A00.1 Cholera due to Vibrio cholerae 01, biovar el tor A00.9 Cholera, unspecified A01 Typhoid and paratyphoid fevers A01.0 Typhoid fever A01.1 Paratyphoid fever A A01.2 Paratyphoid fever B A01.3 Paratyphoid fever C A01.4 Paratyphoid fever, unspecified A02 Other salmonella infections A02.0 Salmonella gastroenteritis A02.1 Salmonella septicemia A02.2 Localized salmonella infections A02.8 Other specified salmonella infections A02.9 Salmonella infection, unspecified A03 Shigellosis A03.0 Shigellosis due to Shigella dysenteriae A03.1 Shigellosis due to Shigella flexneri A03.2 Shigellosis due to Shigella boydii A03.3 Shigellosis due to Shigella sonnei A03.8 Other shigellosis A03.9 Shigellosis, unspecified A04 Other bacterial intestinal infections A04.0 Enteropathogenic Escherichia coli infection A04.1 Enterotoxigenic Escherichia coli infection A04.2 Enteroinvasive Escherichia coli infection A04.3 Enterohemorrhagic Escherichia coli infection A04.4 Other intestinal Escherichia coli infections A04.5 Campylobacter enteritis A04.6 Enteritis due to Yersinia enterocolitica A04.7 Enterocolitis due to Clostridium difficile A04.8 Other specified bacterial intestinal infections A04.9 Bacterial intestinal infection, unspecified A05 Other bacterial food-borne intoxications A05.0 Food-borne staphylococcal intoxication A05.1 Botulism A05.2 Food-borne Clostridium perfringens [Clostridium welchii] intoxication A05.3 Food-borne Vibrio parahemolyticus intoxication A05.4 Food-borne Bacillus cereus
    [Show full text]
  • WO 2009/040088 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date PCT (10) International Publication Number 2 April 2009 (02.04.2009) WO 2009/040088 Al (51) International Patent Classification: (74) Agent: ARTH, Hans-Lothar; ABK Patent Attorneys, Jas- A61K 38/08 (2006.01) A61P 25/28 (2006.01) minweg 9, 14052 Berlin (DE). A61P 3/00 (2006.01) A61P 31/00 (2006.01) (81) Designated States (unless otherwise indicated, for every A61P 9/00 (2006.01) A61P 35/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A61P 11/00 (2006.01) A61P 37/00 (2006.01) AO, AT,AU, AZ, BA, BB, BG, BH, BR, BW, BY,BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, (21) International Application Number: EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, PCT/EP2008/008007 IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY,MA, MD, ME, MG, MK, MN, MW, (22) International Filing Date: MX, MY,MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, 9 September 2008 (09.09.2008) RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (25) Filing Language: English ZW (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (30) Priority Data: ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), 07017747.2 11 September 2007 (11.09.2007) EP European (AT,BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT,LU, LV,MC, MT, NL, (71) Applicant (for all designated States except US): MONDO- NO, PL, PT, RO, SE, SI, SK, TR), OAPI (BF, BJ, CF, CG, BIOTECH LABORATORIES AG [UfLl]; Herrengasse CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
    [Show full text]
  • Experimental Histamine Pruritus
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector EXPERIMENTAL HISTAMINE PRURITUS I. INFLUENCE OF PHYSICAL AND PsYcHoLOGIcAL FACTORS ON THRESHOLD REACTIVTTY* FRANK E. CORMIA, M.D. Itching is by far the most common symptom experienced by patients with skin diseases. It may occur in many clinically unrelated syndromes and is often severe when clinical evi- dence of inflammation is absent. The symptom is particularly common and severe in the various cutaneous manifestations of psychosomatic origin. It is especially important, therefore, that both the qualitative and quantitative aspects of itching be subjected to investigative studies. Pertinent data on the nature of itching has been assembled by Goldscheider (1), Lewis, Grant and Marvin (2), Bickford (3) and others. Much of the literature has been sum- marized by Rothman (4). Recently, Graham, Goodell and Wolff (5) have completed an im- portant re-evaluation of itching. There is now a fairly general agreement that itching is a modified form of pain, carried on afferent pain fibers, with subsequent discharge of impulses up the spinothalamic tracts to the sensory cortex. Cowhage does not produce a pure itch, but a severe itch which contains elements of burning and pricking pain (5). Moreover, the itch produced cannot be quantitatively evaluated. Pruritus produced by histamine ionto- phoresis is equally unreliable. Shelley (6) obtained inconstant results with an electrical stimulator. Rothman, in a personal communication, suggested the use of various dilutions of histamine, administered by the intradermal route. Shelley was able to produce a rather constant degree of itching in a majority of subjects tested by the intradermal injection of a controlled dilution of fresh histamine phosphate solution (7) and made valuable sug- gestions regarding the method (6).
    [Show full text]
  • Serum Iron ICD 10 Codes That Meet Medical Necessity Proprietary Information of Unitedhealthcare Community and State
    Serum Iron ICD 10 Codes that Meet Medical Necessity Proprietary Information of UnitedHealthcare Community and State. Copyright 2018 United Healthcare Services, Inc. Unit Codes: CPT Codes: 16027 83540 36009 82728 36134 84446 37642 83550 IRON ICD-10 Codes Covered if selection criteria are met: A01.00 TYPHOID FEVER, UNSPECIFIED A01.01 TYPHOID MENINGITIS A01.02 TYPHOID FEVER WITH HEART INVOLVEMENT A01.03 TYPHOID PNEUMONIA A01.04 TYPHOID ARTHRITIS A01.05 TYPHOID OSTEOMYELITIS A01.09 TYPHOID FEVER WITH OTHER COMPLICATIONS A01.1 PARATYPHOID FEVER A A01.2 PARATYPHOID FEVER B A01.3 PARATYPHOID FEVER C A01.4 PARATYPHOID FEVER, UNSPECIFIED A02.0 SALMONELLA ENTERITIS A02.1 SALMONELLA SEPSIS A02.20 LOCALIZED SALMONELLA INFECTION, UNSPECIFIED A02.21 SALMONELLA MENINGITIS A02.22 SALMONELLA PNEUMONIA A02.23 SALMONELLA ARTHRITIS A02.24 SALMONELLA OSTEOMYELITIS A02.25 SALMONELLA PYELONEPHRITIS A02.29 SALMONELLA WITH OTHER LOCALIZED INFECTION A02.8 OTHER SPECIFIED SALMONELLA INFECTIONS A02.9 SALMONELLA INFECTION, UNSPECIFIED A04.0 ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION A04.1 ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION A04.2 ENTEROINVASIVE ESCHERICHIA COLI INFECTION A04.3 ENTEROHEMORRHAGIC ESCHERICHIA COLI INFECTION A04.4 OTHER INTESTINAL ESCHERICHIA COLI INFECTIONS A04.5 CAMPYLOBACTER ENTERITIS A04.6 ENTERITIS DUE TO YERSINIA ENTEROCOLITICA A04.8 OTHER SPECIFIED BACTERIAL INTESTINAL INFECTIONS A04.9 BACTERIAL INTESTINAL INFECTION, UNSPECIFIED A06.0 ACUTE AMEBIC DYSENTERY A06.1 CHRONIC INTESTINAL AMEBIASIS A06.2 AMEBIC NONDYSENTERIC COLITIS A06.3 AMEBOMA
    [Show full text]